<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05105022</url>
  </required_header>
  <id_info>
    <org_study_id>Ms_203_2021</org_study_id>
    <nct_id>NCT05105022</nct_id>
  </id_info>
  <brief_title>Propofol Versus Sevoflurane for Induction of GA in Infants</brief_title>
  <official_title>The Hemodynamic Effects of Propofol Versus Sevoflurane for Induction of Anesthesia in Healthy Infants as Measured by Electrical Cardiometry: Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This comparative study aims to investigate the haemodynamic safety profile for induction of&#xD;
      general anesthesia in infants 3 months or less guided by electrical cardiometry parameters&#xD;
      versus sevoflurane.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study aims to investigate the hemodynamic effects of both propofol and sevoflurane for&#xD;
      induction of anesthesia in infants less than 3 months of age by electrical cardiometry. The&#xD;
      investigators hypothesized that propofol will have a safe hemodynamic profile for induction&#xD;
      of anesthesia in infants less than 3 months of age as measured by electrical cardiometry in&#xD;
      addition to its favorable pharmacokinetic profile of rapid induction and optimal intubation&#xD;
      conditions.It is conducted at Abu Al Reesh Children's Hospital, Faculty of Medicine, Cairo&#xD;
      University based on an institutional protocol used as a standard of care to induce anesthesia&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2021</start_date>
  <completion_date type="Anticipated">January 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>cardiac index</measure>
    <time_frame>15 minutes</time_frame>
    <description>L/min/m2</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>MAP</measure>
    <time_frame>15 minutes</time_frame>
    <description>mmHg</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">122</enrollment>
  <condition>Induction of General Anesthesia</condition>
  <arm_group>
    <arm_group_label>propofol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Propofol at a dose of 2mg/kg will be administered I.V. .</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sevoflurane</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sevoflurane (4%) will be used for inhalational induction.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>Intravenous induction of general anesthesia in infants 3 months or less.</description>
    <arm_group_label>Sevoflurane</arm_group_label>
    <arm_group_label>propofol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  infants aged 3 months or less scheduled for elective surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  significant structural congenital heart disease&#xD;
&#xD;
          -  intracranial malformation.&#xD;
&#xD;
          -  preexisting hemodynamic instability.&#xD;
&#xD;
          -  history of seizures, opioids, and/or hypnotic administration.&#xD;
&#xD;
          -  prematurity (defined as gestational age &lt;37 weeks)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>90 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Shymaa Fathy, MD</last_name>
    <phone>+201000455897</phone>
    <phone_ext>002</phone_ext>
    <email>angel6122003@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Faculty of Medicine- Cairo University</name>
      <address>
        <city>Cairo</city>
        <zip>11562</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shymaa Fathy, MD</last_name>
      <phone>23649281</phone>
      <phone_ext>002</phone_ext>
      <email>pg@kasralainy.edu.eg</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 25, 2021</study_first_submitted>
  <study_first_submitted_qc>October 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 3, 2021</study_first_posted>
  <last_update_submitted>October 22, 2021</last_update_submitted>
  <last_update_submitted_qc>October 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Shymaa Fathy</investigator_full_name>
    <investigator_title>Lecturer of anesthesia and SICU</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

